Clinical Trial Update: Selenium Intervention Registry Randomized Trial in Heart Failure [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating selenium supplementation in patients with various forms of heart failure is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Failure with Mid-range Ejection Fraction
• Heart Failure with Preserved Ejection Fraction
• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Selenium (selenium)

Snippet

Sponsor: Skane University Hospital | Conditions: Heart Failure, Heart Failure and Reduced Ejection Fraction | Phase 3 | Status: RECRUITING